Clinical Trial Update: Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant treatment with anti-PD1 immunotherapy followed by maintenance in patients with resectable head and neck mucosal melanoma is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Mucosal Melanoma

Drugs mentioned

• Anti-PD1 Immunotherapy

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Head and Neck Mucosal Melanomas | Phase 2 | Status: ACTIVE_NOT_RECRUITING